These are very exciting times for diabetes technology. There are so many product launches in the pipeline that are expected to make life hassle-free (Well, almost). Most of the emerging technologies show excellent potential in improving glucose outcomes that matter.
Steve Pacelli, executive vice president at biotech company Dexcom, says they are revolutionizing the way people check their blood sugar. The Dexcom’s G5 Mobile app is expected to provide world’s first continuous glucose monitoring system on your compatible smart device. The system is made of three parts: a handheld receiver that monitors your levels, a wireless transmitter and a self-inserted sensor. Real-time glucose data and trends can be viewed right on your phone and data can be shared with loved ones and caregivers.
The website claims that it is the only FDA-approved CGM System that lets you make treatment decisions without pricking your finger. Dexcom is working to refine its sensor enough to get it down to size of a band aid.
“We believe that the accuracy and performance we can achieve with products like that will be much better than people will be able to produce from a non-invasive perspective,” Pacelli says.